3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totaling 395,582 shares, an increase of 646.4% from the April 15th total of 53,000 shares. Based on an average trading volume of 236 shares, the short-interest ratio is presently 1,676.2 days.
3SBio Price Performance
3SBio stock opened at $2.85 on Tuesday. The firm’s 50 day simple moving average is $2.77 and its 200-day simple moving average is $3.19. 3SBio has a fifty-two week low of $2.22 and a fifty-two week high of $4.74.
About 3SBio
3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.
The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.
See Also
- Five stocks we like better than 3SBio
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
